Enantiomeric determination of pantoprazole in human plasma by multidimensional high-performance liquid chromatography

被引:92
作者
Cass, QB
Degani, ALG
Cassiano, NM
Pedrazolli, J
机构
[1] Univ Fed Sao Carlos, Dept Quim, BR-13565970 Sao Carlos, SP, Brazil
[2] Univ Sao Francisco, Escola Med, Unidade Farmacol Clin, BR-12900000 Braganca Paulista, SP, Brazil
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2002年 / 766卷 / 01期
基金
巴西圣保罗研究基金会;
关键词
enantiomer separation; pantoprazole;
D O I
10.1016/S0378-4347(01)00472-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Multidimensional HPLC is a powerful tool for the analysis of samples of a high degree of complexity. This work reports the use of multidimensional HPLC by coupling a RAM column with a chiral polysaccharide column to the analysis of Pantoprazole in human plasma by direct injection. The enantiomers from the plasma samples were separated with high resolution on a tris(3,5-dimethoxyphenylcarbamate) of amylose phase after clean-up by a RAM BSA octyl column. Water was used as solvent for the first 5 min in a flow-rate of 1.0 ml/min for the elution of the plasmatic proteins and then acetonitrile-water (35:65 v/v) for the transfer and analysis of pantoprazole enantiomers, which were detected by UV at 285 nm. Analysis time was 28 min with no time spent on sample preparation. A good linear relationship was obtained in the concentration range of 0.20 to 1.5 mug/ml for each enantiomer. Inter and intra-day precision and accuracy were determined by one low (0.24 mug/ml), one medium (0.70 mug/ml) and one high (1.3 mug/ml) plasma concentration and gave a CV varying from 1.80 to 8.43% and accuracy from 86 to 92%. Recoveries of pantoprazole enantiomers were in the range of 93.7-101.2%. The validated method was applied to the analysis of the plasma samples obtained from ten Brazilian volunteers who received an 80 mg oral dose of racemic pantoprazole and was able to quantify the enantiomers of pantoprazole in all clinical samples analyzed. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 24 条
[1]   Pharmacokinetics, metabolism and interactions of acid pump inhibitors - Focus on omeprazole, lansoprazole and pantoprazole [J].
Andersson, T .
CLINICAL PHARMACOKINETICS, 1996, 31 (01) :9-28
[2]   STEREOSELECTIVE EFFECTS IN THE SEPARATION OF ENANTIOMERS OF OMEPRAZOLE AND OTHER SUBSTITUTED BENZIMIDAZOLES ON DIFFERENT CHIRAL STATIONARY PHASES [J].
BALMER, K ;
PERSSON, BA ;
LAGERSTROM, PO .
JOURNAL OF CHROMATOGRAPHY A, 1994, 660 (1-2) :269-273
[3]  
Boos KS, 1997, LC GC-MAG SEP SCI, V15, P602
[4]   The use of a polysaccharide-based column on multimodal elution [J].
Cass, QB ;
Degani, ALG ;
Cassiano, N .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2000, 23 (07) :1029-1038
[5]   Enantioseparation on amylose tris(3,5-dimethoxyphenyl carbamate): Application to commercial pharmaceutical chiral drugs [J].
Cass, QB ;
Tiritan, ME ;
Calafatti, SA ;
Matlin, SA .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1999, 22 (20) :3091-3099
[6]   Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: Comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype [J].
Chang, M ;
Dahl, ML ;
Tybring, G ;
Gotharson, E ;
Bertilsson, L .
PHARMACOGENETICS, 1995, 5 (06) :358-363
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF THE H+/K+ ATPASE INHIBITOR (BY-1023/SK+F96022) AND ITS SULFONE METABOLITE IN SERUM OR PLASMA BY DIRECT INJECTION AND FULLY AUTOMATED PRECOLUMN SAMPLE CLEANUP [J].
HUBER, R ;
MULLER, W ;
BANKS, MC ;
ROGERS, SJ ;
NORWOOD, PC ;
DOYLE, E .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 529 (02) :389-401
[9]   Determination of R(+)- and S(-)-lansoprazole using chiral stationary-phase liquid chromatography and their enantioselective pharmacokinetics in humans [J].
Katsuki, H ;
Yagi, H ;
Arimori, K ;
Nakamura, C ;
Nakano, M ;
Katafuchi, S ;
Fujioka, Y ;
Fujiyama, S .
PHARMACEUTICAL RESEARCH, 1996, 13 (04) :611-615
[10]   HPLC WITH CARBOHYDRATE CARBAMATE CHIRAL PHASES - INFLUENCE OF CHIRAL PHASE-STRUCTURE ON ENANTIOSELECTIVITY [J].
MATLIN, SA ;
TIRITAN, ME ;
CRAWFORD, AJ ;
CASS, QB ;
BOYD, DR .
CHIRALITY, 1994, 6 (02) :135-140